MAPT and red-green color blindness: In this article, we use ‘CBD’ to refer only to cases with a neuropathologically confirmed tau pathology affecting glia and neurons in a characteristic distribution.2 We use ‘CBD mimic’ to refer to cases of clinically-suspected CBD where the postmortem pathology was not CBD.